Elite Pharmaceuticals Inc (ELTP)

[sharkey1]

Got it, didn't know about Jerome Stevens, WOW, what a tumble

The fourth threat I discussed was the result of revenues lost when Jerome Stevens cancelled their agreement with LCI and revenues stopped in March 2019. Despite the many drug launches LCI has claimed since then, the revenues captured are not filling the 31 percent of revenues lost when JSP took their products to Amneal (AMRX) for distribution.

Interestingly, Amneal’s share price movement since that point suggests the deal has not worked out as well as expected…at least for Amneal, which saw its share price peak at about $25 with the JSP announcement in 2018. But it has steadily declined and, as of this writing, Amneal’s share price sits at $4.63.


So, Lannett needs Elite now, I think they got the message. At one time long long time ago when Lannett was at 8 bucks, thought to my self, that would be a good match for merger, and were off to the races, but not now.